Beyond Batch Release: Responsible Decision-Making, Professional Judgement, and Governance in Complex Pharmaceutical Manufacturing

Responsible decision-making in pharmaceutical manufacturing increasingly occurs within complex, distributed, and rapidly evolving environments. While the European Qualified Person (QP) holds defined regulatory accountability, modern decision contexts extend beyond compliance verification and require integration of scientific understanding, lifecycle knowledge, and organisational governance. Building on recent discussions surrounding technological evolution and regulatory expectations, this review explores how professional judgement operates in environments characterised by uncertainty, accelerating timelines, and expanding organisational interfaces.Specification compliance alone often provides insufficient confidence for decision-making. Confidence increasingly emerges through process understanding, integration of multidisciplinary expertise, and development of coherent scientific narratives that connect data, process behaviour, and patient expectations. Accelerated environments also reveal how governance structures and organisational systems influence decision quality, highlighting the importance of clear accountability, trusted expertise, and independent judgement.This paper introduces the concept of patient-relevant decision quality and discusses how experienced professionals contribute to continuity of understanding across lifecycle stages. Seen through this lens, the QP represents one perspective within a broader system of responsible decision-making, where organisational maturity, principled leadership, and stewardship of judgement support scientifically grounded and ethically sound outcomes.